MTR Target

Company Overview

Snapshot

Founded in January 2013 by Zami Yerushalmy and Dr. Iliya Kusner, MTR Target operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on product development and cooperation with medical imaging companies and medical centers.

Business overview

MTR Target develops medical image-processing CAD applications designed to enhance the efficiency of diagnosis, detection, and classification of lesions. Its core product, the MTR CT Reader, is an automatic application that identifies and categorizes lung nodules as malignant, benign, or requiring follow-up. The technology aims to replicate the knowledge and experience of practicing radiologists, serving the healthcare industry, particularly hospitals and medical centers, within the Health Tech & Life Sciences sector.

Company Intelligence Q&A

What is MTR Target's primary focus?

MTR Target specializes in developing medical image-processing CAD applications to improve the efficiency of diagnosis, detection, and classification of lesions.

What is the MTR CT Reader?

The MTR CT Reader is a fully automatic application developed by MTR Target that detects and classifies lung nodules into 'malignant,' 'benign,' and 'need to follow-up' categories.

When was MTR Target founded?

MTR Target was founded in January 2013.

Who are the founders of MTR Target?

MTR Target was co-founded by Zami Yerushalmy, who serves as CEO, and Dr. Iliya Kusner, who is the CTO.

What is MTR Target's current product development strategy?

MTR Target is cooperating with companies in the medical imaging field and with medical centers as part of its product development efforts.